CD4 and neoplasm: These CD4 effector T cells elicited by anti-CTLA-4 mAb improved anti-tumor responses by enhancing CD8 T cell infiltration, and cytolytic CD8 activity, demonstrating that PD-1 and CTLA-4 attenuate T cell activation though distinct molecular and cellular mechanisms.